LAKEN PATIN: Open Payments
NPI 1205554912 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 51 payments from 13 companies in 2025. Trend: 2023 $486 · 2024 $412 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $294 |
| Vanda Pharmaceuticals Inc. | 12 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Alkermes, Inc. | 2 | $32 |
| Indivior Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: VRAYLAR, FANAPT, CAPLYTA, INGREZZA, REXULTI, COBENFY, Qelbree, ARISTADA.
Industry payments across LA — which companies pay providers there.
